Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Clinical Trial to Evaluate the Efficacy of Neuromuscular Taping on Muscle Pain in Patients With Degenerative Osteoarticular Disease of the Spine

NCT07926789 is registered in ClinicalTrials.gov with Consorci Sanitari de l'Alt Penedès i Garraf as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

Get the NCT07926789 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Clinical Trial to Evaluate the Efficacy of Neuromuscular Taping on Muscle Pain in Patients With Degenerative Osteoarticular Disease of the Spine
Lead sponsor
Consorci Sanitari de l'Alt Penedès i Garraf
Phase
Not applicable
Overall status
Not yet recruiting
Start date
January 31, 2027
Completion date
December 31, 2029
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

back pain, low, cervicalgia

Arms

As registered; 2 arms.

  • Intervention Experimentalkinesio taping

    Participants will have neuromuscular tape applied to the neck or lower back after the first exercise session of each week, and remove it on the fourth day

  • Control Sham comparatorsham kinesiotaping

    These patients will have the same tape placed on the same area without tension or therapeutic technique

Primary endpoints

Registered primary outcome measures; 1 primary.

  • Pain Intensity From enrollment to the end of treatment at 4 weeks

    Pain intensity, measured using a Visual Analog Scale (VAS). Pain will be recorded before the first treatment session of each week. Since treatment consists of two physiotherapy sessions per week for four weeks, the VAS will be recorded at the start of sessions 1, 3, 5, and 8, the last of which corresponds to the final day of treatment. In addition, patients will complete a pain diary every day between treatment sessions.

Lead sponsor's other trials

Consorci Sanitari de l'Alt Penedès i Garraf, most recent start first.

Similar trials

Same condition (Neck Pain) and phase, most recent start first.